SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010541
Filing Date
2020-08-13
Accepted
2020-08-13 16:06:36
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20200630x10q.htm 10-Q 1012598
2 EX-31.1 armp-20200630ex3119e1524.htm EX-31.1 15575
3 EX-31.2 armp-20200630ex312f5d922.htm EX-31.2 15361
4 EX-32.1 armp-20200630ex32192a94b.htm EX-32.1 7907
5 EX-32.2 armp-20200630ex3228d162b.htm EX-32.2 8087
6 GRAPHIC armp-20200630x10q001.jpg GRAPHIC 27651
  Complete submission text file 0001558370-20-010541.txt   4309213

Data Files

Seq Description Document Type Size
7 EX-101.INS armp-20200630.xml EX-101.INS 781278
8 EX-101.SCH armp-20200630.xsd EX-101.SCH 40193
9 EX-101.CAL armp-20200630_cal.xml EX-101.CAL 35587
10 EX-101.DEF armp-20200630_def.xml EX-101.DEF 128026
11 EX-101.LAB armp-20200630_lab.xml EX-101.LAB 310512
12 EX-101.PRE armp-20200630_pre.xml EX-101.PRE 273594
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 201099331
SIC: 2836 Biological Products, (No Diagnostic Substances)